Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PALB2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PALB2 (Partner And Localizer of BRCA2) is a DNA repair protein essential for homologous recombination. It plays critical roles in maintaining genomic stability and is associated with Fanconi anemia and increased cancer risk.
No AI portrait yet
| Gene Symbol | PALB2 |
| Full Name | Partner And Localizer of BRCA2 |
| Chromosome | 16p12.2 |
| Function | encodes a critical DNA repair protein that serves as a central hub in the Fanconi anemia pathway and homologous recombination repair. |
| Molecular Weight | 130 kDa |
| Amino Acids | 1186 aa |
| Ensembl ID | ENSG00000083093 |
| GeneCards | PALB2 |
| Human Protein Atlas | PALB2 |
| FA core complex | PALB2 interacts with the FA core complex |
| ID complex | Works with FANCD2-I (FANCI) for downstream signaling |
| BRCA complex | Part of the BRCA1-PALB2-BRCA2-RAD51 complex |
| Crosslink repair | Essential for interstrand crosslink repair |
| Associated Diseases | Cancer |
| Interactions | BRCA1, DNA, RAD18, UBIQUITIN |
| KG Connections | 57 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
PALB2["PALB2"]
Als{"Als"}
PALB2 -->|"therapeutic target"| Als
Ms{"Ms"}
PALB2 -->|"therapeutic target"| Ms
Cancer{"Cancer"}
PALB2 -->|"associated with"| Cancer
Carcinoma{"Carcinoma"}
PALB2 -->|"therapeutic target"| Carcinoma
PALB2 -->|"regulates"| Cancer
Ataxia{"Ataxia"}
PALB2 -->|"regulates"| Ataxia
GENE_MUTATIONS["GENE MUTATIONS"]
PALB2 -->|"therapeutic target"| GENE_MUTATIONS
ATM["ATM"]
PALB2 -->|"associated with"| ATM
BRCA2["BRCA2"]
PALB2 -->|"associated with"| BRCA2
CDH1["CDH1"]
PALB2 -->|"regulates"| CDH1
RAD51["RAD51"]
PALB2 -->|"regulates"| RAD51
NF1["NF1"]
PALB2 -->|"regulates"| NF1
CDKN2A["CDKN2A"]
CDKN2A -->|"associated with"| PALB2
TP53["TP53"]
TP53 -->|"associated with"| PALB2
CANCER["CANCER"]
CANCER -->|"associated with"| PALB2
MLH1["MLH1"]
MLH1 -->|"associated with"| PALB2
BRCA1["BRCA1"]
BRCA1 -->|"associated with"| PALB2
ATM -->|"regulates"| PALB2
TP53 -->|"regulates"| PALB2
NBN["NBN"]
NBN -->|"regulates"| PALB2
BRIP1["BRIP1"]
BRIP1 -->|"regulates"| PALB2
STK11["STK11"]
STK11 -->|"regulates"| PALB2
CHEK2["CHEK2"]
CHEK2 -->|"regulates"| PALB2
CANCER -->|"regulates"| PALB2
style PALB2 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Als | therapeutic_target | disease | 0.75 |
| Ms | therapeutic_target | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Carcinoma | therapeutic_target | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Ataxia | regulates | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Breast Cancer | therapeutic_target | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Als | activates | disease | 0.65 |
| DNA | activates | gene | 0.60 |
| T Cell | activates | cell_type | 0.60 |
| UBIQUITIN | activates | gene | 0.60 |
| autophagy pathway | participates_in | pathway | 0.60 |
| neurons | expressed_in | cell_type | 0.60 |
| GENE MUTATIONS | therapeutic_target | gene | 0.60 |
| PIK3CA | therapeutic_target | gene | 0.60 |
| CDH1 | regulates | gene | 0.60 |
| Differentiation | therapeutic_target | pathway | 0.60 |
| GENE MUTATIONS | contributes_to | gene | 0.60 |
| CDH1 | associated_with | gene | 0.60 |
| ATM | associated_with | gene | 0.60 |
| BRCA2 | associated_with | gene | 0.60 |
| RAD51 | regulates | gene | 0.60 |
| NF1 | regulates | gene | 0.60 |
| BRCA2 | regulates | gene | 0.60 |
| PTEN | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CANCER | associated_with | gene | 0.60 |
| CANCER | regulates | gene | 0.60 |
| CANCER | therapeutic_target | gene | 0.60 |
| AND | contributes_to | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| DNA | inhibits | gene | 0.60 |
| CHEK2 | contributes_to | gene | 0.60 |
| BRCA2 | associated_with | gene | 0.60 |
| ATM | contributes_to | gene | 0.60 |
| STK11 | associated_with | gene | 0.60 |
| BRIP1 | contributes_to | gene | 0.60 |
| CDKN2A | associated_with | gene | 0.60 |
| TP53 | associated_with | gene | 0.60 |
| MLH1 | associated_with | gene | 0.60 |
| BRCA1 | associated_with | gene | 0.60 |
| ATM | regulates | gene | 0.60 |
| TP53 | regulates | gene | 0.60 |
| NBN | regulates | gene | 0.60 |
| BRIP1 | regulates | gene | 0.60 |
| STK11 | regulates | gene | 0.60 |
| CHEK2 | regulates | gene | 0.60 |
| PTEN | regulates | gene | 0.60 |
| BRCA1 | regulates | gene | 0.60 |
| RAD18 | activates | gene | 0.60 |
| PTEN | therapeutic_target | gene | 0.60 |
| TP53 | therapeutic_target | gene | 0.60 |
| BRCA1 | therapeutic_target | gene | 0.60 |
| BRCA1 | inhibits | gene | 0.60 |
| ATG7 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning PALB2 in their description or question text
No additional research found